{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:13:30Z","timestamp":1766139210852,"version":"3.41.0"},"reference-count":53,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"unspecified","delay-in-days":173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Summary<\/jats:title>\n\t  <jats:p>Determining the factors that impact the risk for infection with SARS-CoV-2 is a priority as the virus continues to infect people worldwide. The objective was to determine the effectiveness of vaccines and other factors associated with infection among Canadian healthcare workers (HCWs) followed from 15 June 2020 to 1 December 2023. We also investigate the association between antibodies to SARS-CoV-2 and subsequent infections with SARS-CoV-2. Of the 2474 eligible participants, 2133 (86%) were female, 33% were nurses, the median age was 41\u00a0years, and 99.3% had received at least two doses of COVID-19 vaccine by 31 December 2021. The incidence of SARS-CoV-2 was 0.91 per 1000 person-days. Prior to the circulation of the Omicron variants, vaccine effectiveness (VE) was estimated at 85% (95% CI 1, 98) for participants who received the primary series of vaccine. During the Omicron period, relative adjusted VE was 43% (95% CI 29, 54), 56% (95% CI 42, 67), and 46% (95% CI 24, 62) for 3, 4, and\u00a0\u2265\u00a05 doses compared with those who received primary series after adjusting for previous infection and other covariates. Exposure to infected household members, coworkers, or friends in the previous 14\u00a0days were risk factor for infection, while contact with an infected patient was not statistically significant. Participants with higher levels of immunoglobulin G (IgG) anti-receptor binding domain (RBD) antibodies had lower rates of infection than those with the lowest levels. COVID-19 vaccines remained effective throughout the follow-up of this cohort of highly vaccinated HCWs. IgG anti-RBD antibody levels may be useful as correlates of protection for issues such as vaccine development and testing. There remains a need to increase the awareness among HCWs about the risk of contracting SARS-CoV-2 from contacts at a variety of venues.<\/jats:p>","DOI":"10.1017\/s0950268825100101","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:01:07Z","timestamp":1750672867000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for infection with SARS-CoV-2 in a cohort of Canadian healthcare workers: 2020\u20132023"],"prefix":"10.1017","volume":"153","author":[{"given":"Brenda L.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Valiquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne M.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeya","family":"Nadarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Powis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranya","family":"Arnoldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Smieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freda","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Colwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Claude","family":"Gingras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"S0950268825100101_r2","unstructured":"[2] World Health Organization. (2024) WHO COVID-19 Dashboard. https:\/\/data.who.int\/dashboards\/covid19\/ (accessed 6 December 2024)."},{"key":"S0950268825100101_r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.10.022"},{"key":"S0950268825100101_r11","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0222-2024"},{"key":"S0950268825100101_r31","first-page":"495","article-title":"Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers \u2013 Eight U.S. locations, December 2020\u2013March 2021","volume":"2021","author":"Thompson","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268825100101_r42","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7145"},{"key":"S0950268825100101_r45","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqab141"},{"key":"S0950268825100101_r51","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-023-00139-8"},{"key":"S0950268825100101_r53","unstructured":"[53] Government of Canada. (2024) Interim Guidance on the use of Rapid Antigen Detection Tests for the Identification of SARS-CoV-2 Infection. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/2019-novel-coronavirus-infection\/guidance-documents\/use-rapid-antigen-detection-tests.html. (accessed 15 September 2024)."},{"key":"S0950268825100101_r16","volume-title":"Correlates of Vaccine-Induced Protection: Methods and Implications","year":"2013"},{"key":"S0950268825100101_r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281673"},{"key":"S0950268825100101_r12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118691"},{"key":"S0950268825100101_r6","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-023-01300-5"},{"key":"S0950268825100101_r35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081942"},{"key":"S0950268825100101_r26","unstructured":"[26] Government of Canada. Coronavirus Disease 2019 (COVID-19): Epidemiology Update. https:\/\/health-infobase.canada.ca\/covid-19\/ (accessed 28 March 2024)."},{"key":"S0950268825100101_r10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00015-2"},{"key":"S0950268825100101_r22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142362"},{"key":"S0950268825100101_r1","unstructured":"[1] World Health Organization. (2023) Coronavirus Disease (COVID-19) Pandemic. https:\/\/www.who.int\/europe\/emergencies\/situations\/covid-19 (accessed 07 November 2024)."},{"key":"S0950268825100101_r37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842912"},{"key":"S0950268825100101_r25","volume-title":"Stata Statistical Software: Release 18","year":"2023"},{"key":"S0950268825100101_r40","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01568-24"},{"key":"S0950268825100101_r49","doi-asserted-by":"publisher","DOI":"10.3201\/eid1904.111812"},{"key":"S0950268825100101_r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100809"},{"key":"S0950268825100101_r20","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11061077"},{"key":"S0950268825100101_r27","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/68.2.373"},{"key":"S0950268825100101_r28","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1201200202"},{"key":"S0950268825100101_r52","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060682"},{"key":"S0950268825100101_r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100546"},{"key":"S0950268825100101_r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106293"},{"key":"S0950268825100101_r3","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-023-00848-4"},{"key":"S0950268825100101_r4","doi-asserted-by":"publisher","DOI":"10.1139\/facets-2021-0029"},{"key":"S0950268825100101_r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.05.038"},{"key":"S0950268825100101_r47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.01.009"},{"key":"S0950268825100101_r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.01.020"},{"key":"S0950268825100101_r19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29839"},{"key":"S0950268825100101_r44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/s-0043-1766118","article-title":"Transmission and risk factors of COVID-19 among health care workers","volume":"44","author":"Alghader","year":"2023","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"S0950268825100101_r17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22146-8"},{"key":"S0950268825100101_r24","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00539-2"},{"key":"S0950268825100101_r23","first-page":"309","article-title":"Feasibility and acceptability of self-collected dried blood spots for SARS-CoV-2 vaccine response in community-dwelling elderly: A large decentralized prospective study","volume":"7","author":"Abubakar","year":"2023","journal-title":"Journal of Community Medicine and Public Health"},{"key":"S0950268825100101_r32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010061"},{"key":"S0950268825100101_r33","unstructured":"[33] National Center for Immunization and Respiratory Diseases. COVID-19 Vaccine Effectiveness. https:\/\/www.cdc.gov\/ncird\/whats-new\/covid-19-vaccine-effectiveness.html (accessed 7 December 2024)."},{"key":"S0950268825100101_r18","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02189-x"},{"key":"S0950268825100101_r34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55245-9"},{"key":"S0950268825100101_r39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077714"},{"key":"S0950268825100101_r7","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.108"},{"key":"S0950268825100101_r48","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12301"},{"key":"S0950268825100101_r50","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-01995-z"},{"key":"S0950268825100101_r29","doi-asserted-by":"publisher","DOI":"10.1155\/cjid\/1858884"},{"key":"S0950268825100101_r9","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21111501"},{"key":"S0950268825100101_r8","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.442"},{"key":"S0950268825100101_r21","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121835"},{"key":"S0950268825100101_r5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3582"},{"key":"S0950268825100101_r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.10.072"},{"key":"S0950268825100101_r38","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09338-5"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268825100101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:01:10Z","timestamp":1750672870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268825100101\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":53,"alternative-id":["S0950268825100101"],"URL":"https:\/\/doi.org\/10.1017\/s0950268825100101","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is used to distribute the re-used or adapted article and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e72"}}